tiprankstipranks
Trending News
More News >
Aequus Pharmaceuticals (TSE:AQS)
:AQS
Canadian Market

Aequus Pharmaceuticals (AQS) Income Statement

Compare
14 Followers

Aequus Pharmaceuticals Income Statement

Last quarter (Q4 2024), Aequus Pharmaceuticals's total revenue was C$221.95K, an increase of 336.25% from the same quarter last year. In Q4, Aequus Pharmaceuticals's net income was C$-217.81K. See Aequus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 584.24KC$ 254.90KC$ 1.38MC$ 2.71MC$ 2.59M
Gross Profit
C$ 199.97KC$ 143.66KC$ 1.15MC$ 2.69MC$ 2.59M
Operating Expenses
C$ 2.33MC$ 2.96MC$ 3.64MC$ 4.06MC$ 3.12M
Depreciation and Amortization
C$ 132.33KC$ 138.16KC$ 129.83KC$ 128.11KC$ 210.97K
EBITDA
C$ -1.79MC$ -2.68MC$ -2.87MC$ -1.23MC$ -314.80K
Operating Income
C$ -2.13MC$ -2.82MC$ -2.50MC$ -1.35MC$ -521.57K
Other Income/Expenses
C$ -50.46KC$ -144.44KC$ -712.01KC$ -442.14KC$ -519.26K
Pretax Income
C$ -2.18MC$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05M
Net Income
C$ -2.18MC$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.01
Diluted EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.01C$ -0.01
Weighted Average Shares Outstanding
132.63M 132.63M 132.63M 128.85M 93.18M
Weighted Average Shares Outstanding (Diluted)
132.63M 132.63M 132.63M 128.85M 93.18M
Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis